Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study
Crossref DOI link: https://doi.org/10.1007/s40744-016-0043-1
Published Online: 2016-09-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kivitz, Alan
Wallace, Thomas
Olech, Ewa
Borofsky, Michael
Devenport, Jenny
Pei, Jinglan
Michalska, Margaret
Funding for this research was provided by:
Genentech